BUZZ-Macquarie forecasts FY25 EBITDA below consensus for Australia's Sonic Healthcare

Reuters07-01

** Analysts at Macquarie forecast FY25 EBITDA of A$1.69 bln($1.13 bln) for Sonic Healthcare , which sits 8% below Visible Alpha consensus

** Brokerage maintains "Neutral" rating and price target of A$26.35/shr

** Shares of SHL were down as much as 1.6% in early trade, hitting lowest level since June 26

** Macquarie says brokerage forecasts imply a return on equity $(ROE)$ of 6-7% over FY24-FY26 for SHL on lower return on net operating assets and reduced leverage compared to historic levels

** Brokerage says weaker than expected FY25 EBITDA guidance reflects challenging operating environment

** Five of 15 analysts covering the stock rate it "buy" or higher, seven rate "hold" and three rate "sell" or lower; their median PT is A$26.68 - LSEG data

** Stock down 18% YTD, as of last close

($1 = 1.4999 Australian dollars)

(Reporting by Shivangi Lahiri in Bengaluru)

((shivangi.lahiri@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment